FindTrial
Sign In

Study on the pathogenesis of liver fibrosis

Study on the pathogenesis of liver fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073427
Enrollment
Unknown
Registered
2023-07-11
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic fibrosis

Interventions

Control group:N/A
Hepatic fibrosis group:N/A

Sponsors

Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: From January 1, 2022 to December 31, 2023, non-living liver transplantation was performed in the liver transplantation department of the Third Affiliated Hospital of Sun Yat-sen University, aged 18 to 75 years old.

Exclusion criteria

Exclusion criteria: Donor ?75-year-old, liver transplantation with severe fatty liver and living donor liver transplantation with relatives.

Design outcomes

Primary

MeasureTime frame
Expression changes of candidate factors such as SOX4 and Mettl3 in liver fibrosis tissues;—

Secondary

MeasureTime frame
Correlation between the expression changes of candidate factors in liver fibrosis tissues and the progress of liver fibrosis;—

Countries

China

Contacts

Public ContactXu Yan

Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-sen University

xuyan55@mail.sysu.edu.cn+86 180 2800 5832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026